Bavarian Nordic secures $120m US BARDA contract for vaccine production
The bulk product, worth $96m, will be made and invoiced in 2023, but it will only partially replenish…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Aug 23
The bulk product, worth $96m, will be made and invoiced in 2023, but it will only partially replenish…
04 Aug 23
The expanded agreement includes the renewal of the non-exclusive total laboratory solution collaboration agreement and an eco-social collaboration…
04 Aug 23
The partnership builds upon the companies' existing collaboration, which centres around the development and commercialisation of pelacarsen
04 Aug 23
Start-up US biotech company tackling rare diseases presents three case studies in France
04 Aug 23
Increased manufacturing capacity combined with an expansion from 69 to 92 eligible countries, is expected to enable delivery…
03 Aug 23
The programme, which combines Google Cloud's Vertex AI platform with Cognizant’s AI domain expertise and healthcare industry knowledge,…
03 Aug 23
The approval is based on the results of the Phase 3 SUNLIGHT trial in which the combination of…
03 Aug 23
In the lawsuit filed in federal court in Delaware, GSK alleged that Pfizer used many of its vaccine…
03 Aug 23
The company will continue to assess the entire dataset of the late-stage study to determine the drug candidate's…
03 Aug 23
The collaboration intends to leverage T-CAIREM's translational research in AI and FACIT's unique commercialisation-venture model to foster the…